Stock Movers: Novo Nordisk Obesity Pill Approval, J&J Talc Lawsuit, ServiceNow Acquisition

Novo Nordisk Obesity Pill Approval

• 💊 Novo Nordisk received US approval for a pill version of its obesity drug Wegovy, aiming to help with weight loss and maintenance.
• 📈 Shares of Novo Nordisk surged as much as 11%, reflecting the positive news and its competitive edge against rival Eli Lilly.
• 🎯 The approval is based on the Oasis 4 trial, which demonstrated significant body weight loss in participants.

Johnson & Johnson Talc Lawsuit

• ⚖️ Johnson & Johnson was ordered to pay approximately $1.56 billion to a woman who claimed their talc-based baby powder caused her asbestos-linked cancer.
• ⚠️ Researchers have linked asbestos to mesothelioma, and a jury found J&J, its units, and spin-off Kenvue liable for failing to warn about the powder's contamination.
• 📉 J&J's stock experienced a slight decline following the verdict.

ServiceNow Acquisition of Armis

• 🤝 ServiceNow announced a deal to acquire cybersecurity startup Armis for $7.75 billion, marking its largest acquisition to date.
• 💰 The acquisition will be funded through a combination of cash on hand and debt, with an expected closing in the second half of 2026.
• 📉 Shares of ServiceNow saw a decrease of up to 2.9% on the news of the deal.